Show simple item record

dc.contributor.authorNouman, Arshad
dc.contributor.authorIndah, Sukmawati
dc.contributor.authorUpul, wickramarachchi
dc.contributor.authorShrilla, Banerjee
dc.contributor.authorAaysha, Cader, Fathima
dc.date.accessioned2024-09-23T09:53:05Z
dc.date.available2024-09-23T09:53:05Z
dc.date.issued2024-06-24
dc.identifier.citationArshad N, Sukmawati I, Wickramarachchi U, Banerjee S, Cader FA. Routine Functional Testing or Standard Care in High-Risk Patients after Percutaneous Coronary Intervention. Curr Cardiol Rep. 2024 Jun;26(6):497-503. doi: 10.1007/s11886-024-02064-z. Epub 2024 May 9. PMID: 38722493en_US
dc.identifier.issn15233782
dc.identifier.issn15233782
dc.identifier.urihttp://hdl.handle.net/20.500.12904/18957
dc.description.abstractPurpose of review: This review aimed to collate the available evidence on outcomes following routine functional stress testing vs standard of care (i.e. symptom-guided stress testing) in high-risk patients following percutaneous coronary intervention (PCI). Recent findings: The most recent pragmatic POST-PCI trial provided randomized evidence showing that routine functional stress testing post-PCI did not lead to a reduction in 2-year ischemic cardiovascular events or all-cause mortality, as compared to a symptom-guided standard-of-care approach. This was also true for sub-analyses including multivessel or left main disease, diabetics, as well as following imaging or physiology guided PCI. In the absence of a change in their clinical or functional status suggestive of stent failure, post-PCI routine periodic stress testing in stable patients on guideline-directed medical therapy is currently not recommended by American clinical practice guidelines. While evidence on the cost-effectiveness of routine stress testing strategy is scarce, physician, payer, and policy-level interventions to reduce inappropriate use of routine functional testing need to be addressed.
dc.language.isoenen_US
dc.publisherCurrent Cardiology Reporten_US
dc.subjectFunctional stress testingen_US
dc.subjectHigh-risk patientsen_US
dc.subjectPercutaneous coronary interventionen_US
dc.titleRoutine Functional Testing or Standard Care in High-Risk Patients after Percutaneous Coronary Interventionen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2024-06-24
html.description.abstractPurpose of review: This review aimed to collate the available evidence on outcomes following routine functional stress testing vs standard of care (i.e. symptom-guided stress testing) in high-risk patients following percutaneous coronary intervention (PCI). Recent findings: The most recent pragmatic POST-PCI trial provided randomized evidence showing that routine functional stress testing post-PCI did not lead to a reduction in 2-year ischemic cardiovascular events or all-cause mortality, as compared to a symptom-guided standard-of-care approach. This was also true for sub-analyses including multivessel or left main disease, diabetics, as well as following imaging or physiology guided PCI. In the absence of a change in their clinical or functional status suggestive of stent failure, post-PCI routine periodic stress testing in stable patients on guideline-directed medical therapy is currently not recommended by American clinical practice guidelines. While evidence on the cost-effectiveness of routine stress testing strategy is scarce, physician, payer, and policy-level interventions to reduce inappropriate use of routine functional testing need to be addressed.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record